Using luciferase-reporter SIVmac239 in 293T cells coexpressing CD4, the authors measured entry via huSTRL33 at 24,043Β±2,993 RLU versus 1,885Β±61 RLU via rhSTRL33 β a ~13-fold defect that persisted with AU1-tagged receptors (~25-fold) and was not explained by expression levels, as Western blots showed comparable protein abundance . By contrast, both human and rhesus CCR5 and GPR15 functioned comparably, showing the species-dependence is STRL33-specific.
N-terminal 64-aa swaps fully transferred coreceptor activity between species. Among seven N-terminal differences, only the serine mattered: R31S in rhSTRL33 restored hu-level function, while S30R in huSTRL33 reduced entry ~20-fold; N-terminal tyrosine variants (H4Y, Y6H, H7Y, Y10D) had only 2β4-fold effects . Crucially, sooty mangabey STRL33 (GenBank AF237559) retains Ser31 and supported entry by SIVmac239, SIVmac316, and SIVsmΞB670 cl.3 comparable to huSTRL33 .
The authors conclude STRL33 is unlikely to matter in the SIVmac/rhesus model (since its natural receptor is incompatible) but could contribute in naturally infected mangabeys. This fits the broader pattern that CCR5 remains central and GPR15 adds little in vivo. Related work supports species-specific receptor divergence shaping lentiviral tropism: SIVrcmNG411 uses CCR2B and STRL33 but not CCR5, consistent with the high CCR5-Ξ24 frequency in red-capped mangabeys , and Bonzo/STRL33 is coordinately regulated with CCR5 on memory T cells, consistent with a possible physiological entry cofactor in natural hosts .
Strengths: clean mutational logic, orthogonal readouts (luciferase and GFP across five Envs), expression controls, and sequence-deposition transparency. Weaknesses: all functional data are from overexpressing 293T cells β physiological STRL33 density is likely far lower (the authors themselves note STRL33 needs higher expression than CCR5); only three mangabeys were sequenced; and in vivo relevance in macaques is inferred, not demonstrated. The in-vitro-only caveat parallels that of the soluble-CD4 SIV literature, where cell-line artifacts (e.g., sCD4 enhancement of SIVagm) did not translate directly . Later work confirmed non-CCR5 pathways (GPR15, CXCR6) operate in primary AGM lymphocytes, partially vindicating the alternative-coreceptor framework .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.